The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of lower-dose pracinostat plus azacitidine safety and efficacy in patients with high/very high-risk myelodysplastic syndromes.
 
Ehab L. Atallah
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Jazz Pharmaceuticals; Novartis; Pfizer
Speakers' Bureau - Abbvie; Jazz Pharmaceuticals; Novartis
Research Funding - Takeda (Inst)
 
Samer K. Khaled
Consulting or Advisory Role - Alexion Pharmaceuticals; Daiichi Sankyo; Omeros
Speakers' Bureau - Alexion Pharmaceuticals
 
Brenda W. Cooper
No Relationships to Disclose
 
Erica D. Warlick
No Relationships to Disclose
 
David A. Ramies
Employment - MEI Pharma; Ramies Consulting, Inc
Leadership - Ramies Consulting, Inc
 
Joanne Li
Employment - MEI Pharma
Stock and Other Ownership Interests - Amgen; Lilly
 
Riccardo Spezia
Employment - Helsinn Healthcare
 
Silvia Mappa
Employment - Helsinn Healthcare
 
Michael Kenneth Keng
Consulting or Advisory Role - Agios